Compound ID | 2765
Class: Beta-lactam
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Broad-spectrum activity (most active against Gram-positive cocci, Escherichia coli, Klebsiella pneumoniae, and Enterobacter sp.); cell wall synthesis inhibitor |
| Description: | Natural product from Streptomyces cattleya; progenitor of N-formimidoyl thienamycin (MK0787; imipenem) |
| Institute where first reported: | Merck Institute for Therapeutic Research, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, U.S.A. 07065; Compania Espanola de ]a Penicilina y Antibioticos S. A., Madrid, Spain |
| Year first mentioned: | 1979 |
| Development status: | Inactive |
| Reason Dropped: | Compound has pharmaceutical limitations (i.e. only active in narrow pH range, temperature, and concentration) |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/441128 |
| Citations: |
|